vs
Side-by-side financial comparison of Karyopharm Therapeutics Inc. (KPTI) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.
Velocity Financial, Inc. is the larger business by last-quarter revenue ($51.6M vs $34.1M, roughly 1.5× Karyopharm Therapeutics Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -299.9%, a 367.2% gap on every dollar of revenue. On growth, Velocity Financial, Inc. posted the faster year-over-year revenue change (32.8% vs 11.6%). Over the past eight quarters, Velocity Financial, Inc.'s revenue compounded faster (32.3% CAGR vs 1.4%).
Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.
KPTI vs VEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.1M | $51.6M |
| Net Profit | $-102.2M | $34.8M |
| Gross Margin | — | — |
| Operating Margin | -52.4% | 97.0% |
| Net Margin | -299.9% | 67.3% |
| Revenue YoY | 11.6% | 32.8% |
| Net Profit YoY | -232.0% | 67.0% |
| EPS (diluted) | $-7.02 | $0.90 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.1M | $51.6M | ||
| Q3 25 | $44.0M | $49.1M | ||
| Q2 25 | $37.9M | $47.6M | ||
| Q1 25 | $30.0M | $37.5M | ||
| Q4 24 | $30.5M | $38.9M | ||
| Q3 24 | $38.8M | $35.1M | ||
| Q2 24 | $42.8M | $32.4M | ||
| Q1 24 | $33.1M | $29.5M |
| Q4 25 | $-102.2M | $34.8M | ||
| Q3 25 | $-33.1M | $25.4M | ||
| Q2 25 | $-37.3M | $26.0M | ||
| Q1 25 | $-23.5M | $18.9M | ||
| Q4 24 | $-30.8M | $20.8M | ||
| Q3 24 | $-32.1M | $15.8M | ||
| Q2 24 | $23.8M | $14.8M | ||
| Q1 24 | $-37.4M | $17.3M |
| Q4 25 | -52.4% | 97.0% | ||
| Q3 25 | -34.6% | 72.1% | ||
| Q2 25 | -64.3% | 71.3% | ||
| Q1 25 | -110.8% | 71.7% | ||
| Q4 24 | -102.4% | 82.5% | ||
| Q3 24 | -67.8% | 60.6% | ||
| Q2 24 | -65.7% | 61.3% | ||
| Q1 24 | -101.9% | 78.8% |
| Q4 25 | -299.9% | 67.3% | ||
| Q3 25 | -75.2% | 51.7% | ||
| Q2 25 | -98.2% | 54.6% | ||
| Q1 25 | -78.2% | 50.4% | ||
| Q4 24 | -100.8% | 53.5% | ||
| Q3 24 | -82.7% | 45.1% | ||
| Q2 24 | 55.6% | 45.6% | ||
| Q1 24 | -112.8% | 58.5% |
| Q4 25 | $-7.02 | $0.90 | ||
| Q3 25 | $-3.82 | $0.65 | ||
| Q2 25 | $-4.32 | $0.69 | ||
| Q1 25 | $-2.77 | $0.51 | ||
| Q4 24 | $-2.33 | $0.56 | ||
| Q3 24 | $-3.85 | $0.44 | ||
| Q2 24 | $-2.97 | $0.42 | ||
| Q1 24 | $-4.85 | $0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $60.5M | $92.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-292.9M | $672.5M |
| Total Assets | $108.4M | $7.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $60.5M | $92.1M | ||
| Q3 25 | $37.7M | $99.0M | ||
| Q2 25 | $38.7M | $79.6M | ||
| Q1 25 | $38.8M | $51.7M | ||
| Q4 24 | $62.5M | $49.9M | ||
| Q3 24 | $72.8M | $44.1M | ||
| Q2 24 | $84.8M | $47.4M | ||
| Q1 24 | $30.6M | $34.8M |
| Q4 25 | $-292.9M | $672.5M | ||
| Q3 25 | $-269.3M | $634.3M | ||
| Q2 25 | $-238.9M | $597.9M | ||
| Q1 25 | $-205.9M | $563.2M | ||
| Q4 24 | $-186.0M | $516.9M | ||
| Q3 24 | $-159.6M | $484.6M | ||
| Q2 24 | $-132.1M | $471.3M | ||
| Q1 24 | $-169.0M | $452.9M |
| Q4 25 | $108.4M | $7.4B | ||
| Q3 25 | $96.2M | $7.0B | ||
| Q2 25 | $104.9M | $6.5B | ||
| Q1 25 | $127.7M | $6.0B | ||
| Q4 24 | $164.4M | $5.5B | ||
| Q3 24 | $189.5M | $5.2B | ||
| Q2 24 | $214.0M | $4.9B | ||
| Q1 24 | $204.5M | $4.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.8M | $18.2M |
| Free Cash FlowOCF − Capex | — | $17.9M |
| FCF MarginFCF / Revenue | — | 34.6% |
| Capex IntensityCapex / Revenue | 0.0% | 0.5% |
| Cash ConversionOCF / Net Profit | — | 0.52× |
| TTM Free Cash FlowTrailing 4 quarters | — | $40.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.8M | $18.2M | ||
| Q3 25 | $-5.9M | $11.5M | ||
| Q2 25 | $-18.7M | $7.7M | ||
| Q1 25 | $-39.0M | $3.5M | ||
| Q4 24 | $-25.8M | $37.8M | ||
| Q3 24 | $-19.5M | $-17.6M | ||
| Q2 24 | $-38.5M | $11.5M | ||
| Q1 24 | $-43.7M | $10.6M |
| Q4 25 | — | $17.9M | ||
| Q3 25 | — | $11.4M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | — | $3.5M | ||
| Q4 24 | $-25.9M | $37.5M | ||
| Q3 24 | — | $-17.6M | ||
| Q2 24 | — | $11.4M | ||
| Q1 24 | $-43.9M | $10.5M |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 23.2% | ||
| Q2 25 | — | 15.9% | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | -84.7% | 96.4% | ||
| Q3 24 | — | -50.3% | ||
| Q2 24 | — | 35.1% | ||
| Q1 24 | -132.6% | 35.8% |
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.2% | 0.7% | ||
| Q3 24 | 0.0% | 0.2% | ||
| Q2 24 | 0.0% | 0.3% | ||
| Q1 24 | 0.6% | 0.1% |
| Q4 25 | — | 0.52× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.29× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 1.81× | ||
| Q3 24 | — | -1.11× | ||
| Q2 24 | -1.62× | 0.78× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KPTI
| Products | $32.1M | 94% |
| License And Other | $2.0M | 6% |
VEL
| Related Party | $19.3M | 37% |
| Nonrelated Party | $16.9M | 33% |
| Other | $15.4M | 30% |
